Literature DB >> 21838706

Insight into the molecular basis for the kinetic differences between the two insulin receptor isoforms.

Louise Knudsen1, Pierre De Meyts, Vladislav V Kiselyov.   

Abstract

More than 20 years after the description of the two IR (insulin receptor) isoforms, designated IR-A (lacking exon 11) and IR-B (with exon 11), nearly every functional aspect of the alternative splicing both in vitro and in vivo remains controversial. In particular, there is no consensus on the precise ligand-binding properties of the isoforms. Increased affinity and dissociation kinetics have been reported for IR-A in comparison with IR-B, but the opposite results have also been reported. These are not trivial issues considering the reported possible increased mitogenic potency of IR-A, and the reported link between slower dissociation and increased mitogenesis. We have re-examined the ligand-binding properties of the two isoforms using a novel rigorous mathematical analysis based on the concept of a harmonic oscillator. We found that insulin has 1.5-fold higher apparent affinity towards IR-A and a 2-fold higher overall dissociation rate. Analysis based on the model showed increased association (3-fold) and dissociation (2-fold) rate constants for binding site 1 of IR in comparison with IR-B. We also provide a structural interpretation of these findings on the basis of the structure of the IR ectodomain and the proximity of the sequence encoded by exon 11 to the C-terminal peptide that is a critical trans-component of site 1.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838706     DOI: 10.1042/BJ20110550

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

Review 1.  Alterations in the expression and activity of pre-mRNA splicing factors in hepatocarcinogenesis.

Authors:  Carmen Berasain; María Elizalde; Raquel Urtasun; Josefa Castillo; Oihane García-Irigoyen; Iker Uriarte; Maria U Latasa; Jesús Prieto; Matías A Avila
Journal:  Hepat Oncol       Date:  2014-03-20

Review 2.  Tailoring of membrane proteins by alternative splicing of pre-mRNA.

Authors:  Kathleen F Mittendorf; Catherine L Deatherage; Melanie D Ohi; Charles R Sanders
Journal:  Biochemistry       Date:  2012-06-29       Impact factor: 3.162

3.  Label-Free Quantification of Small-Molecule Binding to Membrane Proteins on Single Cells by Tracking Nanometer-Scale Cellular Membrane Deformation.

Authors:  Fenni Zhang; Wenwen Jing; Ashley Hunt; Hui Yu; Yunze Yang; Shaopeng Wang; Hong-Yuan Chen; Nongjian Tao
Journal:  ACS Nano       Date:  2018-02-06       Impact factor: 15.881

4.  Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy.

Authors:  William J Gradishar; Denise A Yardley; Rachel Layman; Joseph A Sparano; Ellen Chuang; Donald W Northfelt; Gary N Schwartz; Hagop Youssoufian; Shande Tang; Ruslan Novosiadly; Amelie Forest; Tuan S Nguyen; Jan Cosaert; Dmitri Grebennik; Paul Haluska
Journal:  Clin Cancer Res       Date:  2015-08-31       Impact factor: 12.531

5.  RBM4 promotes pancreas cell differentiation and insulin expression.

Authors:  Jung-Chun Lin; Yu-Ting Yan; Wen-Kou Hsieh; Pey-Jey Peng; Chun-Hao Su; Woan-Yuh Tarn
Journal:  Mol Cell Biol       Date:  2012-11-05       Impact factor: 4.272

6.  Insulin receptor membrane retention by a traceable chimeric mutant.

Authors:  Jimena Giudice; Elizabeth A Jares-Erijman; Federico Coluccio Leskow
Journal:  Cell Commun Signal       Date:  2013-06-27       Impact factor: 5.712

7.  Mechanisms of activation of receptor tyrosine kinases: monomers or dimers.

Authors:  Ichiro N Maruyama
Journal:  Cells       Date:  2014-04-22       Impact factor: 6.600

8.  Quasi-Steady-State Analysis based on Structural Modules and Timed Petri Net Predict System's Dynamics: The Life Cycle of the Insulin Receptor.

Authors:  Jennifer Scheidel; Klaus Lindauer; Jörg Ackermann; Ina Koch
Journal:  Metabolites       Date:  2015-12-17

9.  Comprehensive transcriptome-wide analysis of spliceopathy correction of myotonic dystrophy using CRISPR-Cas9 in iPSCs-derived cardiomyocytes.

Authors:  Sumitava Dastidar; Debanjana Majumdar; Jaitip Tipanee; Kshitiz Singh; Arnaud F Klein; Denis Furling; Marinee K Chuah; Thierry VandenDriessche
Journal:  Mol Ther       Date:  2021-08-08       Impact factor: 11.454

10.  Agonism and antagonism at the insulin receptor.

Authors:  Louise Knudsen; Bo Falck Hansen; Pia Jensen; Thomas Åskov Pedersen; Kirsten Vestergaard; Lauge Schäffer; Blagoy Blagoev; Martin B Oleksiewicz; Vladislav V Kiselyov; Pierre De Meyts
Journal:  PLoS One       Date:  2012-12-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.